Results 191 to 200 of about 54,330 (287)

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

, 2014
David J. Inwards, Paul A. S. Fishkin, Betsy LaPlant, M.T. Drake, Paul J. Kurtin, Daniel A. Nikcevich, Donald B. Wender, Bradley S. Lair, Thomas E. Witzig   +8 more
openalex   +2 more sources

Advances in biomarkers for mantle cell lymphoma in the era of targeted therapies. [PDF]

Haematologica
Loh Z, Yeh P, Keane C, Hawkes EA.
europepmc   +1 more source

Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor [PDF]

Gilles Salles, Jenny M. H. Chen, Ina Zhang, Fábio R. Kerbauy, James J. Wu, Sally W. Wade, Ana Paiva Nunes, Chaoling Feng, Ioana Kloos, Weimin Peng, Julia Thornton Snider, Dylan Maciel, Keith Chan, Sam Keeping, Bijal Shah   +14 more
openalex   +1 more source

Multifaceted cfDNA profiling in mantle cell lymphoma. [PDF]

Blood Adv
Sworder BJ, Herrera AF.
europepmc   +1 more source

Thrombotic microangiopathy associated with mantle cell lymphoma: a case report. [PDF]

BMC Nephrol
Tonouchi Y, Hashimoto K, Iwabuchi R, Sakai H, Nimura T, Yamaka K, Nishikawa M, Yamaguchi A, Sonoda K, Kamijo Y.   +9 more
europepmc   +1 more source

Inhibition of NAMPT targets DNA damage response to sensitize alkylating chemotherapy in TP53 mutant mantle cell lymphoma. [PDF]

Blood Adv
Li N, Liu Y, Zhang L, Guo S, Wu Z, Xu Y, Yang M, Kong J, Che Y, Shao K, Yang H.   +10 more
europepmc   +1 more source

Inhibition of BIRC5 and MCL-1 as a potential treatment strategy to overcome drug resistance in Mantle Cell Lymphoma. [PDF]

Blood Cancer J
Pfitzer J, Chakravarti S, Mazumder S, Li F, Mukherjee UK, Mitra AK.   +5 more
europepmc   +1 more source

Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma

, 2010
Michinori Ogura, Toshiki Uchida, Masafumi Taniwaki, Kiyoshi Ando, Takashi Watanabe, Masanobu Kasai, Yosuke Matsumoto, Daisuke Shimizu, Yoshiaki Ogawa, Ken Ohmachi, Hiroki Yokoyama, Kensei Tobinai, the Japanese Bendamustine Lymphoma Study Group   +12 more
openalex   +2 more sources

Inhibition of CDC20 suppresses the development and progression of mantle cell lymphoma through PI3K/AKT pathway. [PDF]

Ann Hematol
Chen Y, Yang P, Gao S, Liu S, Wang J, Zhang W, Jing H.   +6 more
europepmc   +1 more source

EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma. [PDF]

Hemasphere
Jerkeman M, Aurer I, Campo E, Cheah CY, Clark J, Doorduijn J, Eyre TA, Fehr M, Giné E, Gomes da Silva M, Klener P, Ladetto M, Ribrag V, Shpilberg O, Walewski J, Dreyling M, EHA Guidelines Committee and the European MCL Network.   +16 more
europepmc   +1 more source